|
US7199231B1
(en)
|
1991-05-23 |
2007-04-03 |
Ludwig Institute For Cancer Research |
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
WO2000020445A2
(en)
|
1998-10-02 |
2000-04-13 |
Ludwig Institute For Cancer Research |
Tumor antigens and ctl clones isolated by a novel procedure
|
|
US7311914B2
(en)
|
2002-08-13 |
2007-12-25 |
Ludwig Institute For Cancer Research |
MAGE-A4 antigenic peptides and uses thereof
|
|
WO2004016740A2
(en)
|
2002-08-15 |
2004-02-26 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
|
AU2003259718A1
(en)
|
2003-08-07 |
2005-03-07 |
Epitomics, Inc. |
Methods for humanizing rabbit monoclonal antibodies
|
|
US7807392B1
(en)
|
2003-09-15 |
2010-10-05 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
JP5276846B2
(ja)
|
2005-09-13 |
2013-08-28 |
国立大学法人三重大学 |
Ｔ細胞レセプターをコードする核酸が挿入されてなるベクター及び該レセプターを発現する細胞
|
|
RU2009137582A
(ru)
|
2007-03-12 |
2011-04-20 |
Эсбатек Аг (Ch) |
Инженерия и оптимизация одноцепочечных антител на основе последовательности
|
|
KR20170036814A
(ko)
|
2007-05-21 |
2017-04-03 |
앨더바이오 홀딩스 엘엘씨 |
신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
|
|
EP2164961B1
(en)
|
2007-06-25 |
2015-01-07 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Sequence based engineering and optimization of single chain antibodies
|
|
BRPI0813645A2
(pt)
|
2007-06-25 |
2014-12-30 |
Esbatech Alcon Biomed Res Unit |
Métodos para modificar anticorpos, e anticorpos modificados com propriedades funcionais aperfeiçoadas
|
|
CA2728829C
(en)
|
2008-06-25 |
2018-01-02 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Solubility optimization of immunobinders
|
|
PL2307458T3
(pl)
|
2008-06-25 |
2018-08-31 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Humanizacja przeciwciał króliczych z zastosowaniem uniwersalnego zrębu przeciwciała
|
|
BR112012004546A8
(pt)
*
|
2009-08-29 |
2017-12-05 |
Abbott Lab |
Terapêutica por proteínas ligantes dll4-ligantes
|
|
WO2013048243A1
(en)
|
2011-09-29 |
2013-04-04 |
Apo-T B.V. |
Multi-specific binding molecules targeting aberrant cells
|
|
EP3223907A2
(en)
|
2014-11-26 |
2017-10-04 |
Xencor, Inc. |
Heterodimeric antibodies that bind cd3 and cd38
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
DK3440106T3
(da)
*
|
2016-04-08 |
2021-10-04 |
Adaptimmune Ltd |
T-cellereceptorer
|
|
SMT202200306T1
(it)
|
2016-04-08 |
2022-09-14 |
Immunocore Ltd |
Recettori di cellule t
|
|
BR112018070637A2
(pt)
|
2016-04-08 |
2019-02-05 |
Adaptimmune Ltd |
receptores de células t
|
|
WO2017201493A1
(en)
|
2016-05-20 |
2017-11-23 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment cd3 binding proteins
|
|
EP3509635A1
(en)
*
|
2016-09-06 |
2019-07-17 |
Vavotar Life Sciences LLC |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
US10859566B2
(en)
|
2017-03-20 |
2020-12-08 |
Genocea Biosciences, Inc. |
Treatment methods
|
|
WO2018225732A1
(ja)
*
|
2017-06-05 |
2018-12-13 |
国立大学法人三重大学 |
Ｍａｇｅ－ａ４由来ペプチドを認識する抗原結合性タンパク質
|
|
US20210147550A1
(en)
|
2017-08-18 |
2021-05-20 |
Joshua Michael Francis |
Antigen-binding proteins targeting shared antigens
|
|
EP3731876A4
(en)
|
2017-12-28 |
2022-04-06 |
Gritstone bio, Inc. |
ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
JP7326764B2
(ja)
|
2018-03-09 |
2023-08-16 |
東ソー株式会社 |
腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法
|
|
CA3102254A1
(en)
|
2018-06-04 |
2019-12-12 |
Apo-T B.V. |
Methods and means for attracting immune effector cells to tumor cells
|
|
CN108866098A
(zh)
|
2018-07-27 |
2018-11-23 |
北京安斯晨睿生物科技有限公司 |
携带mage-a4突变抗原基因的重组腺相关病毒载体及其构建方法与应用
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
GB201901306D0
(en)
|
2019-01-30 |
2019-03-20 |
Immunocore Ltd |
Multi-domain binding molecules
|
|
EP3714941A1
(en)
*
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
PH12021553152A1
(en)
|
2019-06-18 |
2022-08-15 |
Regeneron Pharma |
Mage-a4 t cell receptors and methods of use thereof
|
|
EP4004049A1
(en)
|
2019-07-24 |
2022-06-01 |
Regeneron Pharmaceuticals, Inc. |
Chimeric antigen receptors with mage-a4 specificity and uses thereof
|
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
CN110333352A
(zh)
|
2019-08-07 |
2019-10-15 |
基因科技（上海）股份有限公司 |
肿瘤相关自身抗体及肿瘤标志物联合检测试剂盒
|
|
KR20220100963A
(ko)
|
2019-12-18 |
2022-07-18 |
에프. 호프만-라 로슈 아게 |
Hla-a2/mage-a4에 결합하는 항체
|
|
EP4139347A4
(en)
|
2020-04-24 |
2024-06-05 |
Memorial Sloan Kettering Cancer Center |
Anti-cd3 antibodies and uses thereof
|
|
CN116096754A
(zh)
|
2020-05-04 |
2023-05-09 |
免疫里森公司 |
前体三特异性抗体构建体及其使用方法
|
|
EP4149631A1
(en)
|
2020-05-13 |
2023-03-22 |
Adaptimmune Limited |
Method of treatment of cancer or tumour
|
|
US20230190803A1
(en)
|
2020-05-13 |
2023-06-22 |
Adaptimmune Limited |
Method of treatment of cancer or tumour
|
|
CN114524878B
(zh)
|
2020-11-23 |
2024-08-02 |
康诺亚生物医药科技（成都）有限公司 |
一种双特异性抗体及其用途
|
|
US12435444B2
(en)
|
2021-03-09 |
2025-10-07 |
Cdr-Life Ag |
Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same
|
|
MX2023010541A
(es)
|
2021-03-09 |
2023-11-24 |
Cdr Life Ag |
Proteinas de union al antigeno del peptido del mhc mage-a4.
|
|
AU2022271212A1
(en)
|
2021-05-04 |
2023-11-30 |
Regeneron Pharmaceuticals, Inc. |
Chimeric antigen receptors with mage-a4 specificity and uses thereof
|
|
WO2022262678A1
(zh)
|
2021-06-15 |
2022-12-22 |
盛禾(中国)生物制药有限公司 |
一种多特异性抗原结合蛋白及其应用
|
|
US20240327543A1
(en)
|
2021-08-02 |
2024-10-03 |
Shenghe (China) Biopharmaceutical Co., Ltd. |
Multispecific antigen-binding protein and use thereof
|
|
CN117730103A
(zh)
|
2021-08-02 |
2024-03-19 |
盛禾(中国)生物制药有限公司 |
一种多特异性抗原结合蛋白及其应用
|
|
EP4380631A4
(en)
|
2021-08-04 |
2025-06-25 |
Abpro Corporation |
Cd3 targeting antibodies and uses thereof
|
|
EP4377360A4
(en)
|
2021-09-17 |
2025-10-15 |
Adimab Llc |
Anti-cd3 antibodies
|